Roots Analysis has done a detailed study on Global Psychedelic Therapeutics Market, 2020-2030” covering key aspects of the industry and identifying potential future growth opportunities

To order this 250+ page report, which features 120+ figures and 135+ tables, please visit this- https://www.rootsanalysis.com/reports/global-psychedelic-therapeuti...

Key Market Insights
 Nearly 70 players from across the world presently claim to be engaged in the development and evaluation of therapeutic candidates based on a number of psychedelic compounds, such as ketamine and psilocybin
 The pipeline features product candidates based on a variety of psychedelic drug classes, which are being investigated for a wide range of target disease indications, and having different routes of administration
 From a global perspective, this industry is anticipated to evolve significantly over the next few years as federal / regional regulators in different nations are gradually convinced of the clinical significance of this product class
 Several organizations, having realized the untapped opportunity within this emerging segment of psychedelic therapeutics, have awarded grants of over USD 275 million across 500+ instances between 2015-2020
 Several trials evaluating various psychedelic compounds against a wide range of therapeutic indication have been registered in the recent past
 The growing interest is also reflected in the partnership activity since 2017; a number of different types of deals involving various drug classes have been established across multiple geographies
 Presently, North American companies are actively consolidating their indigenous presence through strategic acquisitions; key value drivers behind such deals include both portfolio and geographical expansion
 A number of eminent scientists from renowned universities have emerged as key opinion leaders in this domain, owing to their active involvement in clinical development efforts related to interventions based on psychedelics
 Future market size, based on revenue reported from the sales of marketed and late stage psychedelic-based therapies, is anticipated to be distributed across different therapeutic areas and key geographical regions

For more information, please visit https://www.rootsanalysis.com/reports/global-psychedelic-therapeuti...

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]